Iguana Healthcare Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Iguana Healthcare Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-60,000	Closed	-$2.74M	–	85
2017 Q4	$2.74M	Sell	60,000 -15,000	-20%	-$748K	1.79%	20
2017 Q3	$3.37M	Sell	75,000 -25,000	-25%	-$852K	1.83%	23
2017 Q2	$2.99M	Hold	100,000	–	–	1.69%	23
2017 Q1	$2.22M	Buy	+100,000	New	+$2.14M	1.1%	30

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Iguana Healthcare Management's JUNO Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 60,000 shares — an estimated $2.74M sold.

Iguana Healthcare Management first reported a position in JUNO in Q1 2017 and held it in 4 quarters. The position peaked at $3.37M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Iguana Healthcare Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 60,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2.74M.
Iguana Healthcare Management first reported a position in Juno Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
Iguana Healthcare Management's Juno Therapeutics, Inc. position peaked at $3.37M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.